open access

Vol 1, No 4 (2016)
ORIGINAL PAPERS
Published online: 2017-01-20
Get Citation

The impact of oleanolic and ursolic acid on corneal epithelial cells in vitro

Anna Matysik-Woźniak, Roman Paduch, Ryszard Maciejewski, Anselm G. Jünemann, Robert Rejdak
DOI: 10.5603/OJ.2016.0024
·
Ophthalmology J 2016;1(4):124-132.

open access

Vol 1, No 4 (2016)
ORIGINAL PAPERS
Published online: 2017-01-20

Abstract

INTRODUCTION. Oleanolic (OA) and ursolic (UA) acids belong to the triterpene group widely present in plants. These compounds are recognised to have anti-inflammatory properties and thus are considered to be used in therapies as well as in cosmetic, natural health, or diet products.

AIM. The scientific hypothesis of our study was to show that OA and UA influence corneal epithelial cells cultured in vitro.

METHODS. Toxicity tests, based on MTT and Neutral Red (NR) uptake, measurement of nitric oxide (NOx) level, as well as analysis of metalloproteinases (MMP-2 and MMP-9) amount and activity were performed.

RESULTS . UA expressed significantly higher toxicity on cells than OA. At the lowest concentration applied (5 μM), UA limited cellular metabolism and viability on average by 22% as compared to untreated control, while 25 μM resulted in values lower than 10%. On the other hand, OA at the highest (100 μM) concentration limited cellular metabolism and viability by about 20%. NOx level significantly increased when OA and UA were applied at concentrations of 25 and 100 μM, respectively. OA and UA had a stronger impact on the level of MMP-2 than MMP-9. OA and UA reduced MMP-2 and MMP-9 in the whole range of concentrations. Tested triterpenoids had no significant impact on MMP activity.

CONCLUSIONS. OA and UA have a different impact on human corneal epithelial cells. UA is toxic for corneal epithelial cells, while OA exhibits milder activity, which may be useful for further analysis in ocular pharmacology.

Abstract

INTRODUCTION. Oleanolic (OA) and ursolic (UA) acids belong to the triterpene group widely present in plants. These compounds are recognised to have anti-inflammatory properties and thus are considered to be used in therapies as well as in cosmetic, natural health, or diet products.

AIM. The scientific hypothesis of our study was to show that OA and UA influence corneal epithelial cells cultured in vitro.

METHODS. Toxicity tests, based on MTT and Neutral Red (NR) uptake, measurement of nitric oxide (NOx) level, as well as analysis of metalloproteinases (MMP-2 and MMP-9) amount and activity were performed.

RESULTS . UA expressed significantly higher toxicity on cells than OA. At the lowest concentration applied (5 μM), UA limited cellular metabolism and viability on average by 22% as compared to untreated control, while 25 μM resulted in values lower than 10%. On the other hand, OA at the highest (100 μM) concentration limited cellular metabolism and viability by about 20%. NOx level significantly increased when OA and UA were applied at concentrations of 25 and 100 μM, respectively. OA and UA had a stronger impact on the level of MMP-2 than MMP-9. OA and UA reduced MMP-2 and MMP-9 in the whole range of concentrations. Tested triterpenoids had no significant impact on MMP activity.

CONCLUSIONS. OA and UA have a different impact on human corneal epithelial cells. UA is toxic for corneal epithelial cells, while OA exhibits milder activity, which may be useful for further analysis in ocular pharmacology.

Get Citation

Keywords

corneal epithelial cells, Episkin, metalloproteinases, nitric oxide, oleanolic acid, toxicity model, ursolic acid

About this article
Title

The impact of oleanolic and ursolic acid on corneal epithelial cells in vitro

Journal

Ophthalmology Journal

Issue

Vol 1, No 4 (2016)

Pages

124-132

Published online

2017-01-20

DOI

10.5603/OJ.2016.0024

Bibliographic record

Ophthalmology J 2016;1(4):124-132.

Keywords

corneal epithelial cells
Episkin
metalloproteinases
nitric oxide
oleanolic acid
toxicity model
ursolic acid

Authors

Anna Matysik-Woźniak
Roman Paduch
Ryszard Maciejewski
Anselm G. Jünemann
Robert Rejdak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl